Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-019936
Filing Date
2025-02-13
Accepted
2025-02-13 16:30:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8899
  Complete submission text file 0000950170-25-019936.txt   10396
Mailing Address PHARMACYCLICS INC 995 E ARQUES AVE SUNNYVALE CA 94085-4521
Business Address
MILLER RICHARD A MD (Filed by) CIK: 0001031847 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Subject) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-89443 | Film No.: 25620742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)